Glaxosmithkline Pharmaceuticals Ltd. — filings
Every filing on record for this company. Each row opens the document it names.
| Filing | Period | Scope / kind | Filed | Document |
|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_35655_11336_25052018111215_WEB.xml |
| Results XBRL (NSE) | 2018-06-30 | Standalone | — | INDAS_37346_29726_27072018122331_WEB.xml |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_39400_54244_23102018010836_WEB.xml |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_42197_79554_04022019055402_WEB.xml |
| Results XBRL (NSE) | 2019-03-31 | Standalone | — | INDAS_44445_103141_21052019110505_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Standalone | — | INDAS_46103_123914_23072019110347_WEB.xm |
| Results XBRL (NSE) | 2019-06-30 | Consolidated | — | INDAS_46104_123919_23072019111034_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_48768_156884_23102019124045_WEB.xm |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_48783_156969_23102019024253_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_52283_214260_04022020110259_WEB.xm |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_52284_214266_04022020110636_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55187_259445_19052020024242_WEB.xm |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55188_259448_19052020024428_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_58553_299067_30072020112659_WEB.xm |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_58555_299073_30072020112859_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_62754_353158_31102020125628_WEB.xm |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_62755_353163_31102020125841_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67243_402967_05022021071412_WEB.xm |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67244_402971_05022021071518_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_70102_448932_19052021112545_WEB.xm |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_70103_448935_19052021112813_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_73386_495709_26072021091437_WEB.xm |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_73387_495714_26072021093153_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_77309_549166_30102021124915_WEB.xm |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_77310_549169_30102021125050_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_81430_604025_07022022043144_WEB.xm |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_81431_604030_07022022043255_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_84605_655394_17052022015832_WEB.xm |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_84606_655397_17052022015950_WEB.xm |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_603013_2575_25072022190748_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_860426_4916_11112022180757_WEB.xml |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_861462_4916_11112022180815_WEB.xml |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_88904_788199_08022023104556.xml |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_88905_788202_08022023104747.xml |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_91964_845547_18052023031408.xml |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_91967_845562_18052023031738.xml |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_94650_901258_27072023125413.xml |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_94652_901268_27072023125714.xml |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_100045_983750_09112023071619.xml |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_100056_983822_09112023072652.xml |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_103490_1052145_12022024054226.xml |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_103491_1052151_12022024054343.xml |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_106314_1129169_17052024112941.xml |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_106315_1129174_17052024113143.xml |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_110249_1211246_02082024083405.xml |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_110250_1211249_02082024083552.xml |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_113954_1293849_30102024014750.xml |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_113959_1293877_30102024015746.xml |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_120595_1384344_14022025044131.xml |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_120598_1384358_14022025044347.xml |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1500091_01082025 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1500092_01082025 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1566895_06112025 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1567442_06112025 |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1621943_09022026 |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1621947_09022026 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1666782_13052026 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1666783_13052026 |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1707258_03082026 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1707260_03082026 |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-07-25T12:01:24 | Main_Ind_As_500660_2572018102831.xml |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-10-22T18:19:35 | Main_Ind_As_500660_22102018175447.xml |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-02-04T17:40:04 | Main_Ind_As_500660_422019173946.xml |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-20T17:11:30 | Main_Ind_As_500660_2052019171111.xml |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-20T17:11:30 | Main_Ind_As_500660_2052019171139.xml |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-07-23T10:26:52 | Main_Ind_As_500660_2372019102640.xml |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-07-23T10:26:52 | Main_Ind_As_500660_237201910271.xml |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-10-23T11:50:07 | Main_Ind_As_500660_2310201994918.xml |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-10-23T11:50:07 | Main_Ind_As_500660_2310201994959.xml |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-02-04T12:02:32 | Main_Ind_As_500660_422020102725.xml |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-02-04T12:02:32 | Main_Ind_As_500660_422020103421.xml |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-05-19T08:58:19 | Main_Ind_As_500660_185202023159.xml |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-05-19T08:58:19 | Main_Ind_As_500660_185202023244.xml |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-07-30T13:23:06 | Main_Ind_As_500660_3072020112013.xml |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-07-30T13:23:06 | Main_Ind_As_500660_3072020112037.xml |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-10-29T19:22:37 | Main_Ind_As_500660_29102020161418.xml |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-10-29T19:22:37 | Main_Ind_As_500660_29102020161531.xml |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-05T19:14:47 | Main_Ind_As_500660_52202119657.xml |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-05T19:14:47 | Main_Ind_As_500660_52202119724.xml |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-19T11:10:42 | Main_Ind_As_500660_1952021105234.xml |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-19T11:10:42 | Main_Ind_As_500660_1952021105329.xml |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-07-27T08:40:31 | Main_Ind_As_500660_2672021211022.xml |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-07-27T08:40:31 | Main_Ind_As_500660_2672021211124.xml |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-10-30T14:10:57 | Main_Ind_As_500660_30102021113645.xml |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-10-30T14:10:57 | Main_Ind_As_500660_30102021124235.xml |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-02-07T17:17:07 | Main_Ind_As_500660_722022164018.xml |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-02-07T17:17:07 | Main_Ind_As_500660_72202216415.xml |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-17T16:52:28 | Main_Ind_As_500660_1752022135210.xml |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-17T16:52:28 | Main_Ind_As_500660_1752022135320.xml |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-07-26T11:30:10 | Main_Ind_As_500660_257202219514.xml |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-07-26T11:30:10 | Main_Ind_As_500660_257202219540.xml |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-11-11T17:44:27 | Main_Ind_As_500660_11112022174333.xml |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-11-11T17:44:27 | Main_Ind_As_500660_11112022174440.xml |
| Annual report | 2001-12-31 | grade A | nan | GLAXOSMITHKLINE_PHARMACEUTICALS_LTD-500660-MARCH-2001.PDF |
| Annual report | 2004-12-31 | grade A | nan | GLAXOSMITHKLINE_PHARMACEUTICALS_LTD-500660-MARCH-2004.PDF |
| Annual report | 2012-12-31 | grade A | 2014-03-25T00:00:00 | 5006601213.pdf |
| Annual report | 2014-12-31 | grade B | nan | GLAXOSMITHKLINE_PHARMACEUTICALS_LTD-500660-MARCH-2014.PDF |
| Annual report | 2015-12-31 | grade B | 2015-09-10T00:00:00 | 5006600315.pdf |
| Annual report | 2016-03-31 | grade A | 2016-07-28T00:00:00 | 5006600316.pdf |
| Annual report | 2017-03-31 | grade A | 2017-07-28T00:00:00 | 5006600317.pdf |
| Annual report | 2018-03-31 | grade A | 2018-06-25T00:00:00 | 5006600318.pdf |
| Annual report | 2019-03-31 | grade A | 2019-06-19T00:00:00 | 5006600319.pdf |
| Annual report | 2020-03-31 | grade A | 2020-06-29T00:00:00 | 5006600320.pdf |
| Annual report | 2021-03-31 | grade A | 2021-06-29T00:00:00 | 68671500660.pdf |
| Annual report | 2022-03-31 | grade A | 2022-06-24T00:00:00 | 73292500660.pdf |
| Annual report | 2023-03-31 | grade A | 2023-06-21T17:40:38.953 | b6b29ed5-b0b2-40db-aa46-3efc83311bb8.pdf |
| Annual report | 2024-03-31 | grade A | 2024-06-05T19:40:30.78 | c54a0d2b-0ccf-4c17-9126-88ab6ac4cf55.pdf |
| Annual report | 2025-03-31 | grade A | 2025-06-03T14:51:31.957 | 72fcf18f-8def-4198-9977-dfc64762d12c.pdf |
| Annual report | 2026-03-31 | grade A | 2026-06-05T19:45:09.453 | ce145150-b925-4d9e-b915-b720c933a8c8.pdf |
| Concall | 2024-06-30 | ANALYST_MEET | — | Date_20240808_Glaxosmithkline Pharmaceuticals Ltd._Concal_Un |
| Concall | 2024-09-30 | ANALYST_MEET | — | Date_20241030_Glaxosmithkline Pharmaceuticals Ltd._Concal_Un |
| Concall | 2026-06-30 | ANALYST_MEET | — | Date_20260806_Glaxosmithkline Pharmaceuticals Ltd._Concal_Q1 |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161065_525393_08102021035808_WEB.xml |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_163687_578628_07012022032735_WEB.xml |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_166386_628480_11042022121032_WEB.xml |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_168806_682901_09072022015238_WEB.xml |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_171745_732748_19102022104048_WEB.xml |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176193_814562_11042023050849_WEB.xml |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_178906_884543_14072023022627_WEB.xml |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_180706_942699_09102023103212_WEB.xml |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183379_1010514_08012024035702_WEB.xm |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_185766_1080197_04042024103815_WEB.xm |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_188649_1254829_30092024043459_WEB.xm |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191104_1259432_04102024075650_WEB.xm |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_194653_1345446_14012025074312_WEB.xm |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_197753_1417403_17042025050334_WEB.xm |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1482692_15072025104832_WEB.xml |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1574485_13112025100456_WEB.xml |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1597735_09012026054849_WEB.xml |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1648858_10042026051156_WEB.xml |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1693743_16072026094817_WEB.xml |
| Related-party XBRL | 2022-09-30 | — | — | RPT_GLAXO_22112022115309.xml |
| Related-party XBRL | 2023-03-31 | — | — | RPT_845246_18052023105013_WEB.xml |
| Related-party XBRL | 2023-09-30 | — | — | RPT_983316_09112023055228_WEB.xml |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1129249_18052024114511_WEB.xml |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1293282_29102024085848_WEB.xml |